This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
The Zacks Analyst Blog Highlights: Sleep Number Corp, ASML Holding, UnitedHealth Group, Alcoa Corp and Infosys
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Sleep Number Corp, ASML Holding, UnitedHealth Group, Alcoa Corp and Infosys
5 Stocks Worth Buying on Strong Earnings Reports
by Sejuti Banerjea
Grab these stocks for some quick gains!
UnitedHealth Q3 Solid Result Put Healthcare ETFs in Focus
by Sweta Killa
UnitedHealth reported better-than-expected third-quarter 2020 results wherein it breezed past the Zacks Consensus Estimate on both earnings and revenues. It also lifted its full year outlook.
Stock Market News for Oct 15, 2020
by Zacks Equity Research
Wall Street closed lower for second consecutive days as expectations for a fresh round of fiscal stimulus seems unlikely before the upcoming election.
UnitedHealth's (UNH) Earnings in Q3 Beat on Higher Revenues
by Zacks Equity Research
UnitedHealth's (UNH) Q3 earnings top estimates on solid revenues but the same was down year over year as health care utilization is resuming normalcy.
UnitedHealth Group (UNH) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
UnitedHealth (UNH) delivered earnings and revenue surprises of 17.79% and 2.09%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
5 Must-See Earnings Charts This Week
by Tracey Ryniec
It's not only tech stocks that are breaking out in 2020.
Cigna Set to Grab a Bigger Pie of Medicare Advantage Business
by Zacks Equity Research
Cigna's (CI) Medicare Advantage expansion in new counties and states with attractive prices and a suite of product and service offerings holds promise to widen its market share.
UnitedHealth Expands Offers to Tap Medicare Advantage Market
by Zacks Equity Research
UnitedHealth's (UNH) Medicare Advantage expansion in new counties and states with attractive price and a slew of product and service offerings to grow its market share.
Dow ETF in Focus as Q3 Earnings Kick Off
by Sweta Killa
Nearly one-fourth of the blue chip firms are expected to announce results this week and in the next.
The Zacks Analyst Blog Highlights: Visa, Walmart, Abbott Laboratories, UnitedHealth Group and Oracle
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Visa, Walmart, Abbott Laboratories, UnitedHealth Group and Oracle
What's in the Offing for UnitedHealth (UNH) Earnings in Q3?
by Zacks Equity Research
UnitedHealth's (UNH) Q3 results are likely to reflect a rise in revenues but a decline in earnings.
A Volatile Week Ends with Stocks Broadly Higher
by David Borun
Stimulus talks grind on, but equity investors seem to be pricing in a big package.
Top Research Reports for Visa, Walmart & Abbott
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Visa (V), Walmart (WMT) and Abbott Laboratories (ABT).
Humana Expands Medicare Plans to Boost New Jersey Footprint
by Zacks Equity Research
Humana's (HUM) 2021 Medicare Advantage plans will not only expand its presence in New Jersey but also provide improved health outcomes.
UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $322.41, moving -0.24% from the previous trading session.
Centene's 2021 Medicare Plans to Strengthen U.S. Footprint
by Zacks Equity Research
Centene's (CNC) 2021 health plans will not only expand its presence by 30% in the United States but also provide improved health outcomes for its members.
Analysts Estimate UnitedHealth Group (UNH) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
UnitedHealth (UNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Walmart Ups Health Care Game With Walmart Insurance Services
by Zacks Equity Research
Walmart (WMT) will provide Medicare insurance through Walmart Insurance Services starting on Oct 15.
Cigna's Acquisitions, Diversified Businesses to Aid Growth
by Zacks Equity Research
Cigna's (CI) expanded business portfolio and favorable cash flow generation to contribute to the stock's prospects.
Humana (HUM) Offers Medicare Advantage Health Plans for 2021
by Zacks Equity Research
Humana (HUM) unveils 2021 Medicare product offerings and better benefits in more counties across the nation.
Cigna's 2021 Improved Health Plans to Expand Member Base
by Zacks Equity Research
Cigna's (CI) 2021 health plans with enhanced features will not only expand its presence by 22% in the United States but also provide improved health outcomes.
UnitedHealth Arm Rolls Out Enhanced Health Plans for 2021
by Zacks Equity Research
UnitedHealth Group's (UNH) unit, UnitedHealthcare, reveals cost-effective health plans for 2021. This is likely to expand the company's U.S. footprint.
Stocks Rise Even as New Uncertainties Loom
by David Borun
The events of a wild week were quickly overshadowed by the US President's positive Covid-19 test results.
The Zacks Analyst Blog Highlights: Alibaba, UnitedHealth, Merck & Co., Chipotle Mexican Grill and IDEXX Laboratories
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Alibaba, UnitedHealth, Merck & Co., Chipotle Mexican Grill and IDEXX Laboratories